查看購物車
  • Simplified Chinese
  • English
  • Japanese
全球 VNA/PACS 市場（按產品類型、模式、應用、最終用戶和地區分類）- 預測至 2030 年
市場調查報告書
商品編碼
1740254

全球 VNA/PACS 市場（按產品類型、模式、應用、最終用戶和地區分類）- 預測至 2030 年

Vendor Neutral Archive & PACS Market by Product Type, Modality, Application, End User & Region - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 289 Pages | 訂單完成後即時交付

價格

預計到 2030 年，全球 VNA 和 PACS 市場規模將達到 79.2 億美元，高於 2025 年的 51 億美元，預測期內的複合年成長率為 9.2%。

市場擴張的關鍵促進因素包括醫療圖像資料的快速成長、企業級互通性的提升，以及對用於最佳化影像工作流程的供應商中立集中式平台日益成長的需求。此外，醫療數位化措施以及促進交換醫療資訊的法規結構也進一步推動了市場成長。然而，高昂的實施成本和資料遷移的複雜性仍然是採用先進 VNA/PACS 的主要障礙，尤其對於中小型醫療機構而言。

研究範圍
調查年份 2024-2030
基準年 2024
預測期 2024-2030
單元 10億美元
部分 產品類型、模式、部署、供應商類型、應用程式、最終用戶、地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東和非洲

根據產品類型，多站點 VNA 部分預計在預測期內見證最高成長率。

醫療圖像解決方案需求的不斷成長，主要源自於醫療保健系統日益重視互通性和跨站點資料整合，以最佳化跨地域的影像工作流程。隨著醫院和醫療保健系統整合成整合網路，建立全面的影像儲存庫對於促進無縫資料存取和協作診斷至關重要。此外，新冠疫情加劇了向遠距離診斷、遠端諮詢和虛擬護理框架的轉變，凸顯了對可擴展、多站點 VNA 的需求，這些 VNA 能夠隨時隨地安全地存取醫療圖像。這類先進的解決方案不僅有助於打破資料孤島、最大限度地減少影像重複，還能增強不同部門和機構之間的護理協調。

根據部署情況，內部部署部分在 2024 年佔據了最大的市場佔有率。

醫療保健機構越來越傾向於在本地部署基礎設施，以保持監管監督並實現長期成本可預測性。這些機構優先考慮安全性和性能穩定性，這與資本預算實踐相符。內部儲存管理可確保符合嚴格的資料管治標準，同時始終提供可靠的影像效能。該領域的一個重要考慮因素是總擁有成本 (TCO)。雖然雲端基礎的解決方案通常提供更高的靈活性並減少前期投資，但本地部署通常能提供更好的長期投資收益(ROI)，尤其對於擁有現有 IT 團隊且成像量需求固定的機構而言。此外，硬體效率的提高使本地部署更加經濟可靠。

按地區分類，預計亞太地區在 2025 年至 2030 年期間的複合年成長率最高。

預計亞太市場將見證最高的複合年成長率，這得益於新興經濟體對醫療圖像基礎設施的投資不斷增加、醫療保健服務的不斷擴大以及醫院系統的快速數位化。隨著印度、中國和東南亞等國家不斷提高其影像診斷能力，醫療機構正在尋求集中式、可互通的解決方案來管理臨床影像和相關數據。同時，技術進步和雲端運算的日益普及使得企業影像解決方案（尤其是 VNA 和 PACS）在各種規模的醫療機構中更具擴充性和成本效益。隨著數位健康策略成為國家必要事項，人們越來越注重最佳化成像工作流程、促進對放射學數據的遠端存取以及促進跨設施的數據互通性。這些舉措與支援整合和無縫成像資訊管理的 VNA 和 PACS 平台所提供的固有優勢相吻合。

本報告對全球 VNA 和 PACS 市場進行了深入分析，包括關鍵促進因素和限制因素、競爭格局和未來趨勢。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 主要發現

  • VNA/PACS市場概述
  • 亞太地區 VNA 和 PACS 市場（按產品類型和國家分類）
  • VNA/PACS 市場：地理成長機會
  • VNA/PACS市場：區域細分
  • VNA/PACS市場：已開發市場與新興市場

第5章市場概述

  • 介紹
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
    • 任務
  • 產業趨勢
    • 雲端採用
    • 人工智慧和機器學習整合
    • 基於價值的護理模式
  • 技術分析
    • 主要技術
    • 互補技術
    • 相關技術
  • 影響客戶業務的趨勢/中斷
  • 價值鏈分析
  • 生態系分析
  • 投資金籌措場景
  • 波特五力分析
  • 主要相關利益者和採購標準
  • 大型會議和活動（2025-2026年）
  • 定價分析
    • 2024年VNA和PACS解決方案平均銷售價格（以產品類型）
    • 各地區 VNA/PACS 解決方案平均銷售價格（定性）
  • 監管分析
    • 監管機構、政府機構和其他組織
    • 法規結構
  • 專利分析
    • 討論：管轄權和主要申請人分析
    • 主要專利清單（2020-2024）
  • 案例研究分析
  • 未滿足的需求和最終用戶的期望
  • 經營模式
    • 企業授權模式
    • SaaS 模型
    • 計量收費模式
    • 混合模式
  • 美國關稅對 VNA/PACS 市場的影響（2025 年）
    • 介紹
    • 主要關稅稅率
    • 價格影響分析
    • 對國家的影響
    • 對終端產業的影響
    • 結論

第6章 VNA/PACS 市場（按模式）

  • 介紹
  • CT
  • 乳房X光攝影
  • 超音波
  • MRI
  • X光
  • PET

第7章 VNA/PACS 市場（按部署模型）

  • 介紹
  • 本地部署模型
  • 雲端基礎的部署模型
  • 混合部署模型

第 8 章 VNA/PACS 市場（依產品類型）

  • 介紹
  • VNA
    • 越通社部門
    • 多部門 VNA
    • 多站點 VNA
  • PACS
    • 部門 PACS
    • 多部門 PACS
    • 多站點 PACS

第9章 VNA/PACS 市場（依供應商類型）

  • 介紹
  • 獨立供應商
  • 第三方供應商

第 10 章 VNA/PACS 市場：按應用

  • 介紹
  • 心
  • 整形外科
  • 瘤
  • 神經
  • 婦產科
  • 其他用途

第 11 章 VNA/PACS 市場（按最終用戶）

  • 介紹
  • 醫院和診所
  • 診斷中心
  • 門診手術中心
  • 其他最終用戶

第12章 VNA/PACS 市場（按地區）

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 亞太宏觀經濟展望
    • 日本
    • 中國
    • 印度
    • 其他亞太地區
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中東和非洲
    • 中東和非洲宏觀經濟展望
    • 海灣合作理事會國家
    • 其他中東和非洲地區

第13章競爭格局

  • 介紹
  • 主要參與企業的策略/優勢
  • 收益分析（2020-2024）
  • 市場佔有率分析（2024年）
  • 企業評估矩陣：主要企業（2024年）
  • 公司評估矩陣：Start-Ups/中小企業（2024 年）
  • 公司估值和財務指標
    • 財務指標
    • 公司評估
  • 品牌/軟體比較
  • 競爭場景

第14章 公司簡介

  • 主要企業
    • AGFA-GEVAERT GROUP
    • FUJIFILM HOLDINGS CORPORATION
    • SECTRA AB
    • GE HEALTHCARE
    • MERATIVE
    • KONINKLIJKE PHILIPS NV
    • CANON MEDICAL SYSTEMS CORPORATION
    • INTELERAD. INTELERAD.
    • PAXERAHEALTH
    • NOVARAD CORPORATION
    • HYLAND SOFTWARE, INC.
    • SIEMENS HEALTHINEERS AG
    • BRIDGEHEAD SOFTWARE LTD.
    • CANOPY PARTNERS
    • CRELIOHEALTH INC.
    • ASPYRA, LLC
    • POSTDICOM
    • MEDICASOFT
    • ESAOTE SPA
    • VISUS HEALTH IT GMBH
  • 其他公司
    • ADVAHEALTH SOLUTIONS
    • SOFTTEAM SOLUTIONS PVT. LTD.
    • ARO SYSTEMS
    • CENTRAL DATA NETWORKS
    • ONEPACS
    • DEDALUS SPA

第15章 附錄

Product Code: HIT 2128

The global VNA & PACS market is projected to reach USD 7.92 billion by 2030 from USD 5.10 billion in 2025, at a CAGR of 9.2% during the forecast period. Market expansion is largely fueled by the surging volume of medical imaging data, the transition towards enterprise-wide interoperability, and the increasing demand for centralized, vendor-neutral platforms designed to optimize imaging workflows. Additionally, initiatives aimed at healthcare digitization and regulatory frameworks promoting health information exchange are further catalyzing market growth. However, the high costs associated with implementation and the complexities related to data migration remain significant barriers to the adoption of advanced VNA and PACS, particularly for small to mid-sized healthcare organizations.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2024-2030
Units ConsideredValue (USD billion)
SegmentsProduct Type, Modality, Deployment, Vendor Type, Application, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

On the basis of product type, the multi-site VNA segment is expected to witness the highest growth rate during the forecast period.

Based on product type, the VNA & PACS market is segmented into VNA (further subsegmented into department, multi-department, and multi-site VNA) and PACS (further subsegmented into department, multi-department, and multi-site PACS). The multi-site VNA subsegment is expected to witness the fastest CAGR during the forecast period. The escalating demand for medical imaging solutions is primarily driven by the increasing emphasis of healthcare systems on interoperability and cross-institutional data integration to optimize imaging workflows across diverse geographical locations. As hospitals and health systems consolidate into integrated networks, the establishment of a comprehensive imaging repository has become essential for facilitating seamless data access and collaborative diagnostic efforts. Additionally, the transition towards remote diagnostics, teleconsultations, and virtual care frameworks-exacerbated by the COVID-19 pandemic-has underscored the imperative for scalable, multi-site VNAs that enable secure and anytime-anywhere access to medical imaging. These advanced solutions not only help dismantle data silos and minimize image duplication but also enhance care coordination across various departments and facilities.

On the basis of deployment, the on-premises deployment segment held the largest market share in 2024.

On the basis of deployment, the VNA & PACS market has been segmented into on-premises, cloud-based, and hybrid deployment. The on-premises deployment segment held the largest market share in 2024. Healthcare institutions are increasingly favoring on-premises deployment in infrastructure to maintain oversight and achieve long-term cost predictability, particularly those with substantial resources or large-scale operations. These organizations prioritize security and performance stability, which aligns well with capital budgeting practices. By managing storage internally, they ensure compliance with stringent data governance standards while consistently delivering reliable imaging performance. A critical consideration in this area is the total cost of ownership (TCO). Although cloud-based solutions typically offer greater agility and require a lower upfront investment, on-premises deployment often provides superior long-term return on investment (ROI), especially for institutions equipped with established IT teams and fixed imaging volume requirements. Furthermore, advancements in hardware efficiencies are making local deployments increasingly economical and dependable.

On the basis of region, the Asia Pacific is expected to witness the highest CAGR from 2025 to 2030.

On the basis of region, the VNA & PACS market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Among these, the Asia Pacific market is expected to witness the highest CAGR due to an increased investment in medical imaging infrastructure, expanding healthcare access, and the rapid digitization of hospital systems across emerging economies. Countries such as India, China, and various Southeast Asian nations are enhancing their diagnostic imaging capabilities, leading healthcare organizations to explore centralized and interoperable solutions for the management of clinical images and associated data. Concurrently, technological advancements and the increasing adoption of cloud computing are rendering enterprise imaging solutions-specifically VNA and PACS-more scalable and cost-efficient across institutions of varying sizes. As digital health strategies emerge as national imperatives, there is an intensified focus on optimizing imaging workflows, facilitating remote access to radiological data, and promoting cross-facility data interoperability. These objectives are well-aligned with the inherent advantages offered by VNA and PACS platforms, which support integrated and seamless management of imaging information.

The breakdown of primary participants is as mentioned below:

  • By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
  • By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
  • By Region - North America: 32%, Europe: 30%, Asia Pacific: 25%, Middle East & Africa: 5%, Latin America: 5%

Key Players

The key players functioning in the VNA & PACS market include Hyland Software, Inc. (US), Agfa-Gevaert Group (Belgium), Intelerad Medical Systems Inc. (Canada), Canon Medical Systems Corporation (Japan), FUJIFILM Holdings Corporation (Japan), GE Healthcare (US), Merative (US), Sectra AB (Sweden), Siemens Healthcare Limited (Germany), BridgeHead Software Ltd. (UK), Canopy Partners. (US), Novarad Corporation (US), POSTDICOM (Netherlands), AdvaHealth Solutions Pte Ltd. (Singapore), CrelioHealth (India), Medicasoft (US), Esaote S.p.A. (Italy), PaxeraHealth (US), VISUS Health IT GmbH (Germany), ASPYRA, LLC (US), Dedalus S.p.A. (Italy), SoftTeam Solutions Pvt. Ltd. (India), ARO Systems (Australia), Central Data Networks (Australia), and ONEPACS (US).

Research Coverage:

The report analyses the VNA & PACS market to estimate the market size and future growth potential of various market segments based on product type, modality, deployment, vendor type, application, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report provides valuable insights for both established firms and emerging or smaller players, enabling them to accurately assess market dynamics. By leveraging the information presented, organizations can adopt various strategies outlined below to enhance their competitive positioning and increase market share..

This report provides insights on:

  • Analysis of DROCs: Drivers [increasing investments in medical imaging technologies, growing demand for streamlined healthcare data management solutions, Integration of PACS/VNA with electronic medical records (EMRs)], restraints [increasing data security and privacy concerns, high initial investment, lack of standardized protocols and interoperability frameworks], opportunities [government initiatives to increase penetration of AI in medical imaging, Increasing medical imaging procedures and large imaging data silos, rapid uptake of big data in healthcare], and challenges [rising security concerns related to cloud-based image processing and analytics, data security issues] influencing the growth of the VNA & PACS market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product & service launches in the VNA & PACS market
  • Market Development: Comprehensive information on the lucrative emerging markets, product type, modality, deployment, vendor type, application, end user, and region.
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the VNA & PACS market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the VNA & PACS market, such as Agfa-Gevaert Group (Belgium), FUJIFILM Holdings Corporation (Japan), Sectra AB (Sweden), Merative (US), and GE Healthcare (US).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key secondary sources
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key primary sources
      • 2.1.2.2 Key objectives of primary research
      • 2.1.2.3 Key data from primary sources
      • 2.1.2.4 Key primary insights
  • 2.2 RESEARCH DESIGN
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
    • 2.3.2 BOTTOM-UP APPROACH
    • 2.3.3 TOP-DOWN APPROACH
    • 2.3.4 TOP-DOWN APPROACH FOR PARENT MARKET ASSESSMENT
    • 2.3.5 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
  • 2.4 DATA TRIANGULATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RISK ANALYSIS
  • 2.7 RESEARCH LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.7.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 OVERVIEW OF VNA & PACS MARKET
  • 4.2 ASIA PACIFIC: VNA & PACS MARKET, BY PRODUCT TYPE AND COUNTRY
  • 4.3 VNA & PACS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 VNA & PACS MARKET: REGIONAL MIX
  • 4.5 VNA & PACS MARKET: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Heightened investments in medical imaging technologies
      • 5.2.1.2 Growing demand for streamlined healthcare data management solutions
      • 5.2.1.3 Integration of PACS/VNA with electronic medical records
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High initial investment for implementing VNA and PACS solutions
      • 5.2.2.2 Lack of standardized protocols and interoperability frameworks
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Favorable government initiatives for better penetration of AI in medical imaging
      • 5.2.3.2 Increasing medical imaging procedures and large imaging data silos
      • 5.2.3.3 Rapid uptake of big data in healthcare
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Rising security concerns related to cloud-based image processing and analytics
      • 5.2.4.2 Data security issues in healthcare settings
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 CLOUD ADOPTION
    • 5.3.2 AI AND ML INTEGRATION
    • 5.3.3 VALUE-BASED CARE MODELS
  • 5.4 TECHNOLOGY ANALYSIS
    • 5.4.1 KEY TECHNOLOGIES
      • 5.4.1.1 Digital imaging and communications in medicine (DICOM)
      • 5.4.1.2 Enterprise imaging solutions
      • 5.4.1.3 Cloud-based storage and services
    • 5.4.2 COMPLEMENTARY TECHNOLOGIES
      • 5.4.2.1 Image exchange networks
      • 5.4.2.2 Data analytics and business intelligence
    • 5.4.3 ADJACENT TECHNOLOGIES
      • 5.4.3.1 Health information exchange (HIE)
  • 5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    • 5.7.1 ROLE IN ECOSYSTEM
  • 5.8 INVESTMENT & FUNDING SCENARIO
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • 5.9.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.9.2 BARGAINING POWER OF SUPPLIERS
    • 5.9.3 BARGAINING POWER OF BUYERS
    • 5.9.4 THREAT OF NEW ENTRANTS
    • 5.9.5 THREAT OF SUBSTITUTES
  • 5.10 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.10.2 KEY BUYING CRITERIA
  • 5.11 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.12 PRICING ANALYSIS
    • 5.12.1 AVERAGE SELLING PRICE OF VNA & PACS SOLUTIONS, BY PRODUCT TYPE, 2024
    • 5.12.2 AVERAGE SELLING PRICE OF VNA & PACS SOLUTIONS, BY REGION (QUALITATIVE)
  • 5.13 REGULATORY ANALYSIS
    • 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.13.2 REGULATORY FRAMEWORK
      • 5.13.2.1 North America
        • 5.13.2.1.1 US
      • 5.13.2.2 Europe
      • 5.13.2.3 Asia Pacific
        • 5.13.2.3.1 China
        • 5.13.2.3.2 Japan
        • 5.13.2.3.3 India
  • 5.14 PATENT ANALYSIS
    • 5.14.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    • 5.14.2 LIST OF MAJOR PATENTS, 2020-2024
  • 5.15 CASE STUDY ANALYSIS
    • 5.15.1 AMBRA HEALTH UTILIZED AWS CLOUD SERVICES TO PROPEL MEDICAL IMAGING PLATFORM GROWTH
    • 5.15.2 NHS TRUST ADOPTED INSTANT DATA ACCESS VNA TO ESTABLISH UNIFIED PLATFORM FOR DICOM IMAGE DATA STORAGE AND MANAGEMENT
  • 5.16 UNMET NEEDS & END-USER EXPECTATIONS
    • 5.16.1 UNMET NEEDS
    • 5.16.2 END-USER EXPECTATIONS
  • 5.17 BUSINESS MODELS
    • 5.17.1 ENTERPRISE LICENSING MODELS
    • 5.17.2 SOFTWARE-AS-A-SERVICE (SAAS) MODELS
    • 5.17.3 PAY-PER-USE MODELS
    • 5.17.4 HYBRID MODELS
  • 5.18 IMPACT OF 2025 US TARIFF ON VNA & PACS MARKET
    • 5.18.1 INTRODUCTION
    • 5.18.2 KEY TARIFF RATES
    • 5.18.3 PRICE IMPACT ANALYSIS
    • 5.18.4 IMPACT ON COUNTRY/REGION
      • 5.18.4.1 North America
        • 5.18.4.1.1 US
      • 5.18.4.2 Europe
      • 5.18.4.3 Asia Pacific
    • 5.18.5 IMPACT ON END-USE INDUSTRIES
      • 5.18.5.1 Hospitals & clinics
      • 5.18.5.2 Diagnostics centers
      • 5.18.5.3 Ambulatory surgery centers
      • 5.18.5.4 Other end users
    • 5.18.6 CONCLUSION

6 VNA & PACS MARKET, BY MODALITY

  • 6.1 INTRODUCTION
  • 6.2 CT
    • 6.2.1 GROWING NEED FOR IMAGING MODALITIES IN MEDICAL FIELDS TO SUPPORT MARKET GROWTH
  • 6.3 MAMMOGRAPHY
    • 6.3.1 RISING INCIDENCE OF BREAST CANCER TO PROPEL MARKET GROWTH
  • 6.4 ULTRASOUND
    • 6.4.1 TECHNOLOGICAL ADVANCEMENTS IN ULTRASOUND DEVICES TO AID MARKET GROWTH
  • 6.5 MRI
    • 6.5.1 COST-EFFECTIVENESS AND EASY AVAILABILITY IN SMALL HEALTHCARE FACILITIES TO FUEL MARKET ADOPTION
  • 6.6 X-RAY
    • 6.6.1 DEVELOPMENTS IN X-RAY IMAGING TO BOOST ADOPTION OF VNA AND PACS SOLUTIONS
  • 6.7 PET
    • 6.7.1 NEED FOR BETTER MANAGEMENT AND STORAGE OF LARGE DATA VOLUMES TO FAVOR MARKET GROWTH

7 VNA & PACS MARKET, BY DEPLOYMENT MODEL

  • 7.1 INTRODUCTION
  • 7.2 ON-PREMISES DEPLOYMENT MODELS
    • 7.2.1 BETTER CONTROL AND SECURITY FOR SENSITIVE PATIENT DATA TO AUGMENT MARKET GROWTH
  • 7.3 CLOUD-BASED DEPLOYMENT MODELS
    • 7.3.1 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING MODALITIES TO DRIVE MARKET
  • 7.4 HYBRID DEPLOYMENT MODELS
    • 7.4.1 GREATER FLEXIBILITY, SCALABILITY, AND CONTROL OVER DATA MANAGEMENT STRATEGIES TO PROPEL MARKET GROWTH

8 VNA & PACS MARKET, BY PRODUCT TYPE

  • 8.1 INTRODUCTION
  • 8.2 VNA
    • 8.2.1 DEPARTMENT VNA
      • 8.2.1.1 Limitations in addressing scalability and interoperability across diverse departments to hinder market growth
    • 8.2.2 MULTI-DEPARTMENT VNA
      • 8.2.2.1 Multi-department VNA to streamline data management processes and reduce redundancies
    • 8.2.3 MULTI-SITE VNA
      • 8.2.3.1 Multi-site VNA to provide centralized repository for managing medical data and standardizing medical records
  • 8.3 PACS
    • 8.3.1 DEPARTMENT PACS
      • 8.3.1.1 Need for better medical imaging data storage to aid market growth
    • 8.3.2 MULTI-DEPARTMENT PACS
      • 8.3.2.1 Technological advancements in multi-department PACS to improve image retrieval speed and ensure data integrity
    • 8.3.3 MULTI-SITE PACS
      • 8.3.3.1 Advancements in cloud-based PACS solutions to propel market growth

9 VNA & PACS MARKET, BY VENDOR TYPE

  • 9.1 INTRODUCTION
  • 9.2 INDEPENDENT VENDORS
    • 9.2.1 INCREASED FLEXIBILITY, BETTER INTEROPERABILITY, AND IMPROVED SOLUTIONS TO DRIVE MARKET
  • 9.3 THIRD-PARTY VENDORS
    • 9.3.1 NEED FOR INNOVATIVE SOLUTIONS TO DRIVE THIRD-PARTY VENDOR PRESENCE

10 VNA & PACS MARKET, BY APPLICATION

  • 10.1 INTRODUCTION
  • 10.2 CARDIOLOGY
    • 10.2.1 RISING CASES OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
  • 10.3 ORTHOPEDIC
    • 10.3.1 GROWING VOLUME AND COMPLEXITY OF ORTHOPEDIC MEDICAL IMAGING SCANS TO PROPEL MARKET GROWTH
  • 10.4 ONCOLOGY
    • 10.4.1 RISING NUMBER OF CANCER CASES TO DRIVE USE OF VNA AND PACS SOLUTIONS FOR ONCOLOGY
  • 10.5 NEUROLOGY
    • 10.5.1 INCREASING DEMAND FOR ADVANCED NEUROLOGICAL IMAGING TECHNOLOGIES TO SPUR GROWTH
  • 10.6 OBSTETRICS & GYNECOLOGY
    • 10.6.1 USE OF 3D AND 4D IMAGING FOR MONITORING FETUS GROWTH AND DIAGNOSING HIGH-RISK PREGNANCIES TO DRIVE MARKET
  • 10.7 OTHER APPLICATIONS

11 VNA & PACS MARKET, BY END USER

  • 11.1 INTRODUCTION
  • 11.2 HOSPITALS & CLINICS
    • 11.2.1 NEED TO IMPROVE PROFITABILITY OF HEALTHCARE SERVICES TO DRIVE USE OF HCIT IN HOSPITALS
  • 11.3 DIAGNOSTIC CENTERS
    • 11.3.1 LACK OF ADVANCED IMAGING MODALITIES IN SMALL AND MID-SCALE HOSPITALS TO AUGMENT MARKET GROWTH
  • 11.4 AMBULATORY SURGERY CENTERS
    • 11.4.1 INCREASING NUMBER OF INTERVENTIONAL IMAGING PROCEDURES TO SUPPORT MARKET GROWTH
  • 11.5 OTHER END USERS

12 VNA & PACS MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 12.2.2 US
      • 12.2.2.1 US to dominate global VNA & PACS market during study period
    • 12.2.3 CANADA
      • 12.2.3.1 Rising cases of end-stage kidney diseases to propel market growth
  • 12.3 EUROPE
    • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 12.3.2 GERMANY
      • 12.3.2.1 Increasing number of MRI units and diagnostic imaging centers to drive market
    • 12.3.3 UK
      • 12.3.3.1 Rising funding and investments in diagnostic imaging to support market growth
    • 12.3.4 FRANCE
      • 12.3.4.1 Rising target patient population and increasing government-funded investments to fuel uptake of VNA and PACS solutions
    • 12.3.5 ITALY
      • 12.3.5.1 Established healthcare infrastructure to aid market growth
    • 12.3.6 SPAIN
      • 12.3.6.1 Growing access to advanced cancer diagnostics to propel market
    • 12.3.7 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 12.4.2 JAPAN
      • 12.4.2.1 Presence of universal healthcare coverage to fuel market
    • 12.4.3 CHINA
      • 12.4.3.1 Strong government support for healthcare reforms and increased number of medical imaging procedures to drive market
    • 12.4.4 INDIA
      • 12.4.4.1 Improving healthcare infrastructure and increasing private-public partnerships to support market growth
    • 12.4.5 REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 12.5.2 BRAZIL
      • 12.5.2.1 Presence of free and universal healthcare system to propel market growth
    • 12.5.3 MEXICO
      • 12.5.3.1 Rapid technological advancements in imaging solutions to support market growth
    • 12.5.4 REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 12.6.2 GCC COUNTRIES
      • 12.6.2.1 Technological integration to spur inclusivity, accessibility, affordability, and growth in healthcare sector
    • 12.6.3 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VNA & PACS MARKET
  • 13.3 REVENUE ANALYSIS, 2020-2024
  • 13.4 MARKET SHARE ANALYSIS, 2024
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 13.5.1 STARS
    • 13.5.2 EMERGING LEADERS
    • 13.5.3 PERVASIVE PLAYERS
    • 13.5.4 PARTICIPANTS
    • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 13.5.5.1 Company footprint
      • 13.5.5.2 Region footprint
      • 13.5.5.3 Product type footprint
      • 13.5.5.4 Deployment model footprint
      • 13.5.5.5 End-user footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 13.6.1 PROGRESSIVE COMPANIES
    • 13.6.2 RESPONSIVE COMPANIES
    • 13.6.3 DYNAMIC COMPANIES
    • 13.6.4 STARTING BLOCKS
    • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 13.6.5.1 Detailed list of key startups/SME players
      • 13.6.5.2 Competitive benchmarking of startups/SME players
  • 13.7 COMPANY VALUATION & FINANCIAL METRICS
    • 13.7.1 FINANCIAL METRICS
    • 13.7.2 COMPANY VALUATION
  • 13.8 BRAND/SOFTWARE COMPARISON
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 PRODUCT LAUNCHES
    • 13.9.2 DEALS
    • 13.9.3 OTHER DEVELOPMENTS

14 COMPANY PROFILES

  • 14.1 KEY COMPANIES
    • 14.1.1 AGFA-GEVAERT GROUP
      • 14.1.1.1 Business overview
      • 14.1.1.2 Solutions offered
      • 14.1.1.3 Recent developments
        • 14.1.1.3.1 Deals
      • 14.1.1.4 MnM view
        • 14.1.1.4.1 Right to win
        • 14.1.1.4.2 Strategic choices
        • 14.1.1.4.3 Weaknesses & competitive threats
    • 14.1.2 FUJIFILM HOLDINGS CORPORATION
      • 14.1.2.1 Business overview
      • 14.1.2.2 Solutions offered
      • 14.1.2.3 Recent developments
        • 14.1.2.3.1 Deals
        • 14.1.2.3.2 Other developments
      • 14.1.2.4 MnM view
        • 14.1.2.4.1 Right to win
        • 14.1.2.4.2 Strategic choices
        • 14.1.2.4.3 Weaknesses & competitive threats
    • 14.1.3 SECTRA AB
      • 14.1.3.1 Business overview
      • 14.1.3.2 Solutions offered
      • 14.1.3.3 MnM view
        • 14.1.3.3.1 Right to win
        • 14.1.3.3.2 Strategic choices
        • 14.1.3.3.3 Weaknesses & competitive threats
    • 14.1.4 GE HEALTHCARE
      • 14.1.4.1 Business overview
      • 14.1.4.2 Solutions offered
      • 14.1.4.3 Recent developments
        • 14.1.4.3.1 Product launches
        • 14.1.4.3.2 Deals
      • 14.1.4.4 MnM view
        • 14.1.4.4.1 Right to win
        • 14.1.4.4.2 Strategic choices
        • 14.1.4.4.3 Weaknesses & competitive threats
    • 14.1.5 MERATIVE
      • 14.1.5.1 Business overview
      • 14.1.5.2 Solutions offered
      • 14.1.5.3 Recent developments
        • 14.1.5.3.1 Deals
      • 14.1.5.4 MnM view
        • 14.1.5.4.1 Right to win
        • 14.1.5.4.2 Strategic choices
        • 14.1.5.4.3 Weaknesses & competitive threats
    • 14.1.6 KONINKLIJKE PHILIPS N.V.
      • 14.1.6.1 Business overview
      • 14.1.6.2 Solutions offered
      • 14.1.6.3 Recent developments
        • 14.1.6.3.1 Product launches
        • 14.1.6.3.2 Deals
    • 14.1.7 CANON MEDICAL SYSTEMS CORPORATION
      • 14.1.7.1 Business overview
      • 14.1.7.2 Solutions offered
      • 14.1.7.3 Recent developments
        • 14.1.7.3.1 Deals
        • 14.1.7.3.2 Expansions
    • 14.1.8 INTELERAD. INTELERAD.
      • 14.1.8.1 Business overview
      • 14.1.8.2 Solutions offered
      • 14.1.8.3 Recent developments
        • 14.1.8.3.1 Deals
        • 14.1.8.3.2 Other developments
    • 14.1.9 PAXERAHEALTH
      • 14.1.9.1 Business overview
      • 14.1.9.2 Solutions offered
    • 14.1.10 NOVARAD CORPORATION
      • 14.1.10.1 Business overview
      • 14.1.10.2 Solutions offered
    • 14.1.11 HYLAND SOFTWARE, INC.
      • 14.1.11.1 Business overview
      • 14.1.11.2 Solutions offered
      • 14.1.11.3 Recent developments
        • 14.1.11.3.1 Deals
    • 14.1.12 SIEMENS HEALTHINEERS AG
      • 14.1.12.1 Business overview
      • 14.1.12.2 Solutions offered
      • 14.1.12.3 Recent developments
        • 14.1.12.3.1 Deals
    • 14.1.13 BRIDGEHEAD SOFTWARE LTD.
      • 14.1.13.1 Business overview
      • 14.1.13.2 Solutions offered
      • 14.1.13.3 Recent developments
        • 14.1.13.3.1 Deals
    • 14.1.14 CANOPY PARTNERS
      • 14.1.14.1 Business overview
      • 14.1.14.2 Solutions offered
    • 14.1.15 CRELIOHEALTH INC.
      • 14.1.15.1 Business overview
      • 14.1.15.2 Solutions offered
    • 14.1.16 ASPYRA, LLC
      • 14.1.16.1 Business overview
      • 14.1.16.2 Solutions offered
    • 14.1.17 POSTDICOM
      • 14.1.17.1 Business overview
      • 14.1.17.2 Solutions offered
    • 14.1.18 MEDICASOFT
      • 14.1.18.1 Business overview
      • 14.1.18.2 Solutions offered
    • 14.1.19 ESAOTE S.P.A.
      • 14.1.19.1 Business overview
      • 14.1.19.2 Solutions offered
      • 14.1.19.3 Recent developments
        • 14.1.19.3.1 Product launches
    • 14.1.20 VISUS HEALTH IT GMBH
      • 14.1.20.1 Business overview
      • 14.1.20.2 Solutions offered
  • 14.2 OTHER PLAYERS
    • 14.2.1 ADVAHEALTH SOLUTIONS
    • 14.2.2 SOFTTEAM SOLUTIONS PVT. LTD.
    • 14.2.3 ARO SYSTEMS
    • 14.2.4 CENTRAL DATA NETWORKS
    • 14.2.5 ONEPACS
    • 14.2.6 DEDALUS S.P.A.

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 VNA & PACS MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 VNA & PACS MARKET: FACTOR ANALYSIS
  • TABLE 3 VNA & PACS MARKET: STUDY ASSUMPTIONS
  • TABLE 4 VNA & PACS MARKET: RISK ANALYSIS
  • TABLE 5 VNA & PACS MARKET: ROLE IN ECOSYSTEM
  • TABLE 6 VNA & PACS MARKET: PORTER'S FIVE FORCES
  • TABLE 7 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR MAJOR END USERS
  • TABLE 8 KEY BUYING CRITERIA FOR MAJOR END USERS
  • TABLE 9 VNA & PACS MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
  • TABLE 10 AVERAGE SELLING PRICE OF PACS SOLUTIONS, BY PRODUCT TYPE, 2024
  • TABLE 11 AVERAGE SELLING PRICE OF VNA SOLUTIONS, BY PRODUCT TYPE, 2024
  • TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR VNA & PACS SOLUTIONS
  • TABLE 17 VNA & PACS MARKET: LIST OF PATENTS/PATENT APPLICATIONS, 2020-2024
  • TABLE 18 CASE STUDY 1: AMBRA HEALTH UTILIZED AWS CLOUD SERVICES TO PROPEL MEDICAL IMAGING PLATFORM GROWTH
  • TABLE 19 CASE STUDY 2: NHS TRUST ADOPTED INSTANT DATA ACCESS TO ESTABLISH UNIFIED PLATFORM FOR DICOM IMAGE DATA STORAGE AND MANAGEMENT
  • TABLE 20 VNA & PACS MARKET: UNMET NEEDS
  • TABLE 21 VNA & PACS MARKET: END-USER EXPECTATIONS
  • TABLE 22 VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 23 VNA & PACS MARKET FOR CT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 24 VNA & PACS MARKET FOR MAMMOGRAPHY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 25 VNA & PACS MARKET FOR ULTRASOUND, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 26 VNA & PACS MARKET FOR MRI, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 27 VNA & PACS MARKET FOR X-RAY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 28 VNA & PACS MARKET FOR PET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 29 VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 30 VNA & PACS MARKET FOR ON-PREMISES DEPLOYMENT MODELS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 31 VNA & PACS MARKET FOR CLOUD-BASED DEPLOYMENT MODELS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 32 VNA & PACS MARKET FOR HYBRID DEPLOYMENT MODELS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 34 VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 35 VNA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 DEPARTMENT VNA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 MULTI-DEPARTMENT VNA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 38 MULTI-SITE VNA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 39 PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 40 PACS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 DEPARTMENT PACS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 MULTI-DEPARTMENT PACS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 MULTI-SITE PACS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 44 VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 45 KEY INDEPENDENT VENDORS OPERATING IN MARKET
  • TABLE 46 VNA & PACS MARKET FOR INDEPENDENT VENDORS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 47 KEY THIRD-PARTY VENDORS OPERATING IN MARKET
  • TABLE 48 VNA & PACS MARKET FOR THIRD-PARTY VENDORS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 49 VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 50 VNA & PACS MARKET FOR CARDIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 51 VNA & PACS MARKET FOR ORTHOPEDIC, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 52 VNA & PACS MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 53 VNA & PACS MARKET FOR NEUROLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 54 VNA & PACS MARKET FOR OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 VNA & PACS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 56 VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 57 VNA & PACS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 58 VNA & PACS MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 59 VNA & PACS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 60 VNA & PACS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 61 VNA & PACS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 62 NORTH AMERICA: VNA & PACS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 63 NORTH AMERICA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 66 NORTH AMERICA: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 67 NORTH AMERICA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 68 NORTH AMERICA: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 69 NORTH AMERICA: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 70 NORTH AMERICA: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 71 US: KEY MACROINDICATORS
  • TABLE 72 US: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 73 US: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 74 US: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 75 US: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 76 US: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 77 US: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 78 US: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 79 US: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 80 CANADA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 81 CANADA: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 82 CANADA: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 83 CANADA: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 84 CANADA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 85 CANADA: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 86 CANADA: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 87 CANADA: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 88 EUROPE: VNA & PACS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 89 EUROPE: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 90 EUROPE: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 91 EUROPE: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 92 EUROPE: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 93 EUROPE: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 94 EUROPE: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 95 EUROPE: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 96 EUROPE: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 97 GERMANY: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 98 GERMANY: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 99 GERMANY: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 100 GERMANY: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 101 GERMANY: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 102 GERMANY: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 103 GERMANY: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 104 GERMANY: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 105 UK: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 106 UK: VNA MARKET, BY TYPE 2023-2030 (USD MILLION)
  • TABLE 107 UK: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 108 UK: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 109 UK: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 110 UK: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 111 UK: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 112 UK: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 113 FRANCE: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 114 FRANCE: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 115 FRANCE: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 116 FRANCE: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 117 FRANCE: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 118 FRANCE: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 119 FRANCE: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 120 FRANCE: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 121 ITALY: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 122 ITALY: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 123 ITALY: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 124 ITALY: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 125 ITALY: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 126 ITALY: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 127 ITALY: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 128 ITALY: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 129 SPAIN: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 130 SPAIN: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 131 SPAIN: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 132 SPAIN: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 133 SPAIN: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 134 SPAIN: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 135 SPAIN: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 136 SPAIN: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 137 REST OF EUROPE: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 138 REST OF EUROPE: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 139 REST OF EUROPE: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 140 REST OF EUROPE: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 141 REST OF EUROPE: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 142 REST OF EUROPE: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 143 REST OF EUROPE: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 144 REST OF EUROPE: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: VNA & PACS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 154 JAPAN: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 155 JAPAN: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 156 JAPAN: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 157 JAPAN: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 158 JAPAN: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 159 JAPAN: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 160 JAPAN: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 161 JAPAN: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 162 CHINA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 163 CHINA: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 164 CHINA: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 165 CHINA: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 166 CHINA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 167 CHINA: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 168 CHINA: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 169 CHINA: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 170 INDIA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 171 INDIA: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 172 INDIA: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 173 INDIA: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 174 INDIA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 175 INDIA: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 176 INDIA: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 177 INDIA: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 178 REST OF ASIA PACIFIC: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 179 REST OF ASIA PACIFIC: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 180 REST OF ASIA PACIFIC: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 181 REST OF ASIA PACIFIC: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 182 REST OF ASIA PACIFIC: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 183 REST OF ASIA PACIFIC: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 184 REST OF ASIA PACIFIC: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 185 REST OF ASIA PACIFIC: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 186 LATIN AMERICA: VNA & PACS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 187 LATIN AMERICA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 188 LATIN AMERICA: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 189 LATIN AMERICA: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 190 LATIN AMERICA: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 191 LATIN AMERICA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 192 LATIN AMERICA: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 193 LATIN AMERICA: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 194 LATIN AMERICA: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 195 BRAZIL: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 196 BRAZIL: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 197 BRAZIL: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 198 BRAZIL: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 199 BRAZIL: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 200 BRAZIL: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 201 BRAZIL: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 202 BRAZIL: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 203 MEXICO: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 204 MEXICO: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 205 MEXICO: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 206 MEXICO: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 207 MEXICO: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 208 MEXICO: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 209 MEXICO: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 210 MEXICO: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 211 REST OF LATIN AMERICA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 212 REST OF LATIN AMERICA: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 213 REST OF LATIN AMERICA: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 214 REST OF LATIN AMERICA: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 215 REST OF LATIN AMERICA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 216 REST OF LATIN AMERICA: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 217 REST OF LATIN AMERICA: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 218 REST OF LATIN AMERICA: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 219 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 220 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 221 MIDDLE EAST & AFRICA: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 222 MIDDLE EAST & AFRICA: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 223 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 224 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 225 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 226 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 227 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 228 GCC COUNTRIES: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 229 GCC COUNTRIES: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 230 GCC COUNTRIES: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 231 GCC COUNTRIES: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 232 GCC COUNTRIES: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 233 GCC COUNTRIES: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 234 GCC COUNTRIES: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 235 GCC COUNTRIES: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 236 REST OF MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 237 REST OF MIDDLE EAST & AFRICA: VNA MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 238 REST OF MIDDLE EAST & AFRICA: PACS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 239 REST OF MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 240 REST OF MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION)
  • TABLE 241 REST OF MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY VENDOR TYPE, 2023-2030 (USD MILLION)
  • TABLE 242 REST OF MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 243 REST OF MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 244 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VNA & PACS MARKET, JANUARY 2022-MAY 2025
  • TABLE 245 VNA & PACS MARKET: DEGREE OF COMPETITION
  • TABLE 246 VNA & PACS MARKET: REGION FOOTPRINT
  • TABLE 247 VNA & PACS MARKET: PRODUCT TYPE FOOTPRINT
  • TABLE 248 VNA & PACS MARKET: DEPLOYMENT MODEL FOOTPRINT
  • TABLE 249 VNA & PACS MARKET: END-USER FOOTPRINT
  • TABLE 250 VNA & PACS MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 251 VNA & PACS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS
  • TABLE 252 VNA & PACS MARKET: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 253 VNA & PACS MARKET: DEALS, JANUARY 2022-MAY 2025
  • TABLE 254 VNA & PACS MARKET: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2025
  • TABLE 255 AGFA-GEVAERT GROUP: COMPANY OVERVIEW
  • TABLE 256 AGFA-GEVAERT GROUP: SOLUTIONS OFFERED
  • TABLE 257 AGFA-GEVAERT GROUP: DEALS, JANUARY 2022-MAY 2025
  • TABLE 258 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 259 FUJIFILM HOLDINGS CORPORATION: SOLUTIONS OFFERED
  • TABLE 260 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2022-MAY 2025
  • TABLE 261 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2025
  • TABLE 262 SECTRA AB: COMPANY OVERVIEW
  • TABLE 263 SECTRA AB: SOLUTIONS OFFERED
  • TABLE 264 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 265 GE HEALTHCARE: SOLUTIONS OFFERED
  • TABLE 266 GE HEALTHCARE: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 267 GE HEALTHCARE: DEALS, JANUARY 2022-MAY 2025
  • TABLE 268 MERATIVE: COMPANY OVERVIEW
  • TABLE 269 MERATIVE: SOLUTIONS OFFERED
  • TABLE 270 MERATIVE: DEALS, JANUARY 2022-MAY 2025
  • TABLE 271 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 272 KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED
  • TABLE 273 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 274 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022-MAY 2025
  • TABLE 275 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
  • TABLE 276 CANON MEDICAL SYSTEMS CORPORATION: SOLUTIONS OFFERED
  • TABLE 277 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2022-MAY 2025
  • TABLE 278 CANON MEDICAL SYSTEMS CORPORATION: EXPANSIONS, JANUARY 2022-MAY 2025
  • TABLE 279 INTELERAD. INTELERAD.: COMPANY OVERVIEW
  • TABLE 280 INTELERAD. INTELERAD.: SOLUTIONS OFFERED
  • TABLE 281 INTELERAD. INTELERAD.: DEALS, JANUARY 2022-MAY 2025
  • TABLE 282 INTELERAD. INTELERAD.: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2025
  • TABLE 283 PAXERAHEALTH: COMPANY OVERVIEW
  • TABLE 284 PAXERAHEALTH: SOLUTIONS OFFERED
  • TABLE 285 NOVARAD CORPORATION: COMPANY OVERVIEW
  • TABLE 286 NOVARAD CORPORATION: SOLUTIONS OFFERED
  • TABLE 287 HYLAND SOFTWARE, INC.: COMPANY OVERVIEW
  • TABLE 288 HYLAND SOFTWARE, INC.: SOLUTIONS OFFERED
  • TABLE 289 HYLAND SOFTWARE, INC.:DEALS, JANUARY 2022-MAY 2025
  • TABLE 290 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 291 SIEMENS HEALTHINEERS AG: SOLUTIONS OFFERED
  • TABLE 292 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022-MAY 2025
  • TABLE 293 BRIDGEHEAD SOFTWARE LTD.: COMPANY OVERVIEW
  • TABLE 294 BRIDGEHEAD SOFTWARE LTD.: SOLUTIONS OFFERED
  • TABLE 295 BRIDGEHEAD SOFTWARE LTD.: DEALS, JANUARY 2022-MAY 2025
  • TABLE 296 CANOPY PARTNERS: COMPANY OVERVIEW
  • TABLE 297 CANOPY PARTNERS: SOLUTIONS OFFERED
  • TABLE 298 CRELIOHEALTH INC.: COMPANY OVERVIEW
  • TABLE 299 CRELIOHEALTH INC.: SOLUTIONS OFFERED
  • TABLE 300 ASPYRA, LLC: COMPANY OVERVIEW
  • TABLE 301 ASPYRA, LLC: SOLUTIONS OFFERED
  • TABLE 302 POSTDICOM: COMPANY OVERVIEW
  • TABLE 303 POSTDICOM: SOLUTIONS OFFERED
  • TABLE 304 MEDICASOFT: COMPANY OVERVIEW
  • TABLE 305 MEDICASOFT: SOLUTIONS OFFERED
  • TABLE 306 ESAOTE S.P.A.: COMPANY OVERVIEW
  • TABLE 307 ESAOTE S.P.A.: SOLUTIONS OFFERED
  • TABLE 308 ESAOTE S.P.A.: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 309 VISUS HEALTH IT GMBH: COMPANY OVERVIEW
  • TABLE 310 VISUS HEALTH IT GMBH: SOLUTIONS OFFERED
  • TABLE 311 ADVAHEALTH SOLUTIONS: COMPANY OVERVIEW
  • TABLE 312 SOFTTEAM SOLUTIONS PVT. LTD.: COMPANY OVERVIEW
  • TABLE 313 ARO SYSTEMS: COMPANY OVERVIEW
  • TABLE 314 CENTRA DATA NETWORKS: COMPANY OVERVIEW
  • TABLE 315 ONEPACS: COMPANY OVERVIEW
  • TABLE 316 DEDALUS S.P.A.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 VNA & PACS MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 VNA & PACS MARKET: YEARS CONSIDERED
  • FIGURE 3 VNA & PACS MARKET: RESEARCH DESIGN
  • FIGURE 4 VNA & PACS MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 VNA & PACS MARKET: PRIMARY SOURCES
  • FIGURE 6 VNA & PACS MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 7 VNA & PACS MARKET: KEY INSIGHTS FROM PRIMARIES
  • FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 9 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 10 SUPPLY-SIDE MARKET ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 11 VNA & PACS MARKET: BOTTOM-UP APPROACH
  • FIGURE 12 VNA & PACS MARKET: TOP-DOWN APPROACH
  • FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN VNA & PACS MARKET
  • FIGURE 14 VNA & PACS MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS)
  • FIGURE 15 VNA & PACS MARKET: DATA TRIANGULATION
  • FIGURE 16 VNA & PACS MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 VNA & PACS MARKET, BY MODALITY, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2025 VS. 2030 (USD MILLION)
  • FIGURE 19 VNA & PACS MARKET, BY VENDOR TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 20 VNA & PACS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 21 VNA & PACS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 22 VNA & PACS MARKET: REGIONAL SNAPSHOT
  • FIGURE 23 NEED TO HANDLE GROWING DATA VOLUME TO FUEL DEMAND FOR VNA AND PACS SOLUTIONS
  • FIGURE 24 JAPAN AND VNA ACCOUNTED FOR SIGNIFICANT MARKET SHARE IN 2024
  • FIGURE 25 CHINA TO REGISTER HIGHEST GROWTH RATE FROM 2025 TO 2030
  • FIGURE 26 ASIA PACIFIC TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 27 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
  • FIGURE 28 VNA & PACS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 29 VNA & PACS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 30 VNA & PACS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 31 VNA & PACS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 32 VNA & PACS MARKET: FUNDING AND NUMBER OF DEALS, 2021-2024
  • FIGURE 33 VNA & PACS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MAJOR END USERS
  • FIGURE 35 KEY BUYING CRITERIA FOR MAJOR END USERS
  • FIGURE 36 JURISDICTION AND TOP APPLICANT ANALYSIS IN VNA & PACS MARKET, JANUARY 2022-MAY 2025
  • FIGURE 37 TOP PATENT APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR VNA & PACS SOLUTIONS (JANUARY 2015-MAY 2025)
  • FIGURE 38 NORTH AMERICA: VNA & PACS MARKET SNAPSHOT
  • FIGURE 39 UK: NUMBER OF MEDICAL IMAGING UNDER NATIONAL HEALTH SERVICE (NHS), JANUARY 2022-JANUARY 2023
  • FIGURE 40 ASIA PACIFIC: VNA & PACS MARKET SNAPSHOT
  • FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN VNA & PACS MARKET, 2020-2024 (USD MILLION)
  • FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VNA & PACS MARKET (2024)
  • FIGURE 43 VNA & PACS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 44 VNA & PACS MARKET: COMPANY FOOTPRINT
  • FIGURE 45 VNA & PACS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 46 EV/EBITDA OF KEY VENDORS
  • FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF VNA AND PACS VENDORS
  • FIGURE 48 VNA & PACS MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
  • FIGURE 49 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT
  • FIGURE 50 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 51 SECTRA AB: COMPANY SNAPSHOT
  • FIGURE 52 GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 53 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 54 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 55 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT